Kardium Receives Funding From the Government of Canada to Expand Manufacturing of the Globe® Pulsed Field System in British Columbia

Kardium Receives Funding From the Government of Canada to Expand Manufacturing of the Globe® Pulsed Field System in British Columbia

The Government of Canada today announced funding of up to $31.25 million through the Strategic Response Fund (SRF) toward Kardium’s investment in a $125 million project to expand its manufacturing capabilities in Vancouver, British Columbia.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827836534/en/

The Globe mapping and ablation catheter from Kardium.

The announcement was made by the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions.

The investment will support a major expansion of Kardium’s cleanroom facility in Vancouver. The new facility will provide the infrastructure needed to support the company’s growth, enabling Kardium to scale up manufacturing of the Globe® System while retaining critical intellectual property, expertise, and high-value jobs in Canada. The Globe System received regulatory approval from Health Canada in July 2026 and the U.S. Food and Drug Administration (FDA) in August 2025.

“British Columbia is emerging as a global hub for medical innovation, home to companies like Kardium that are developing new technologies with the potential to improve lives around the world,” said the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions. “By supporting Kardium’s expansion, the Government of Canada is strengthening Canada’s advanced manufacturing capacity, creating high-value jobs, and ensuring British Columbia remains at the forefront of innovation in the medical sector.”

“Kardium is proud to be developing and manufacturing our innovative medical technology here in British Columbia,” said Kevin Chaplin, Chief Executive Officer of Kardium. “The Government of Canada’s funding is an important step in our continued growth and will help us expand our manufacturing capabilities as we bring our technology to more physicians and patients around the world.”

About the Globe® Pulsed Field System

The Globe System is an integrated cardiac mapping and ablation system designed to advance the treatment of atrial fibrillation (AF), the most common sustained cardiac arrhythmia. It combines high-density mapping and pulsed field ablation in a single catheter, providing physicians with real-time information to guide catheter positioning, assess tissue contact, and deliver targeted treatment.

T: +1.604.248.8891
E: Info@kardium.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260827836534/en/

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center